PHASE-I TRIAL OF COMBINED THERAPY WITH BLEOMYCIN AND THE CALMODULIN ANTAGONIST, TRIFLUOPERAZINE

被引：31

作者：

HAIT, WN

MORRIS, S

LAZO, JS

FIGLIN, RJ

DURIVAGE, HJ

WHITE, K

SCHWARTZ, PE

机构：

[1] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEPT PHARMACOL,NEW HAVEN,CT 06510

[2] YALE UNIV,SCH MED,CTR COMPREHENS CANC,DEPT OBSTET & GYNECOL,NEW HAVEN,CT 06510

[3] UNIV CALIF LOS ANGELES,DEPT INTERNAL MED,LOS ANGELES,CA 90024

来源：

CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1989年 / 23卷 / 06期

关键词：

D O I：

10.1007/BF00435836

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：358 / 362

页数：5

相关论文

共 31 条

[21] LEE G, 1984, LIFE SCI, V36, P347
[22] LEVIN RM, 1976, MOL PHARMACOL, V12, P581
[23] 5-FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN (FAM) COMBINATION CHEMOTHERAPY FOR ADVANCED GASTRIC-CANCER
MACDONALD, JS
SCHEIN, PS
WOOLLEY, PV
SMYTHE, T
UENO, W
HOTH, D
SMITH, F
BOIRON, M
GISSELBRECHT, C
BRUNET, R
LAGARDE, C
[J]. ANNALS OF INTERNAL MEDICINE, 1980, 93 (04) : 533 - 536
[24] CONTROL OF MICROTUBULE ASSEMBLY-DISASSEMBLY BY CALCIUM-DEPENDENT REGULATOR PROTEIN
MARCUM, JM
DEDMAN, JR
BRINKLEY, BR
MEANS, AR
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (08) : 3771 - 3775
[25] MEANS AR, 1982, GENE REGULATION, P307
[26] Meltzer HY, 1983, NEUROLEPTICS NEUROCH, P255
[27] CLINICAL MODULATION OF DOXORUBICIN RESISTANCE BY THE CALMODULIN-INHIBITOR, TRIFLUOPERAZINE - A PHASE-I/II TRIAL
MILLER, RL
BUKOWSKI, RM
BUDD, GT
PURVIS, J
WEICK, JK
SHEPARD, K
MIDHA, KK
GANAPATHI, R
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (05) : 880 - 888
[28] CA2+-DEPENDENT PROTEIN-PHOSPHORYLATION SYSTEM IN MEMBRANES FROM VARIOUS TISSUES, AND ITS ACTIVATION BY CALCIUM-DEPENDENT REGULATOR
SCHULMAN, H
GREENGARD, P
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (11) : 5432 - 5436
[29] TSURUO T, 1981, CANCER RES, V41, P1967
[30] WEI JW, 1983, CANCER CHEMOTH PHARM, V11, P86

← 1 2 3 4 →